标题
Friend or foe: the role of microRNA in chemotherapy resistance
作者
关键词
-
出版物
ACTA PHARMACOLOGICA SINICA
Volume 34, Issue 7, Pages 870-879
出版商
Springer Nature
发表日期
2013-04-29
DOI
10.1038/aps.2013.35
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2
- (2015) Haoran Li et al. Oncotarget
- Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity
- (2015) Swapna Asuthkar et al. Oncotarget
- MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11
- (2015) Vinayakumar Siragam et al. Oncotarget
- miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1
- (2012) X. Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
- (2012) X. Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MicroRNAs: novel factors in clinical diagnosis and prognosis for nasopharyngeal carcinoma
- (2012) Shu Yang et al. ACTA PHARMACOLOGICA SINICA
- A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma
- (2012) Bo-an Li ACTA PHARMACOLOGICA SINICA
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines
- (2012) Yong-Sheng Wang et al. Asian Pacific Journal of Cancer Prevention
- Misprocessing and functional arrest of microRNAs bymiR-Pirate: roles ofmiR-378andmiR-17
- (2012) Zhaoqun Deng et al. BIOCHEMICAL JOURNAL
- Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
- (2012) Leonie JM Mekenkamp et al. BMC CANCER
- MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression
- (2012) Y-S Zang et al. CANCER GENE THERAPY
- MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN
- (2012) Li-Yi Zhang et al. CARCINOGENESIS
- MicroRNAs in Stress Signaling and Human Disease
- (2012) Joshua T. Mendell et al. CELL
- An anti-let-7 sponge decoys and decays endogenous let-7 functions
- (2012) Xiangling Yang et al. CELL CYCLE
- MiR-93 enhances angiogenesis and metastasis by targeting LATS2
- (2012) Ling Fang et al. CELL CYCLE
- Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity
- (2012) Ling Fang et al. FASEB JOURNAL
- The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions
- (2012) Z. J. Rutnam et al. JOURNAL OF CELL SCIENCE
- MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal
- (2012) Linlin Luo et al. JOURNAL OF CELL SCIENCE
- miR-221 and miR-222 promote Schwann cell proliferation and migration by targeting LASS2 after sciatic nerve injury
- (2012) B. Yu et al. JOURNAL OF CELL SCIENCE
- miRNAs regulate expression and function of extracellular matrix molecules
- (2012) Zina Jeyapalan Rutnam et al. MATRIX BIOLOGY
- Lentiviral Transgenic MicroRNA-Based shRNA Suppressed Mouse Cytochromosome P450 3A (CYP3A) Expression in a Dose-Dependent and Inheritable Manner
- (2012) Yong Wang et al. PLoS One
- Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2
- (2012) Fuqiong Chen et al. PLoS One
- Ergosterol Peroxide Isolated from Ganoderma lucidum Abolishes MicroRNA miR-378-Mediated Tumor Cells on Chemoresistance
- (2012) Qing-Ping Wu et al. PLoS One
- The impact of cellular senescence in cancer therapy: is it true or not?
- (2011) Yi Zhang et al. ACTA PHARMACOLOGICA SINICA
- Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy
- (2011) Lin-hui Liang et al. ACTA PHARMACOLOGICA SINICA
- MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma
- (2011) Kai Sun et al. ACTA PHARMACOLOGICA SINICA
- Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells
- (2011) Jie Dong et al. ARCHIVES OF MEDICAL RESEARCH
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting of the Tumor Suppressor GRHL3 by a miR-21-Dependent Proto-Oncogenic Network Results in PTEN Loss and Tumorigenesis
- (2011) Charbel Darido et al. CANCER CELL
- MicroRNA Regulation of Cancer Stem Cells
- (2011) C. Liu et al. CANCER RESEARCH
- Microparticles and their emerging role in cancer multidrug resistance
- (2011) J. Gong et al. CANCER TREATMENT REVIEWS
- A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
- (2011) Marcella Cesana et al. CELL
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
- (2011) Mikael Lerner et al. CELL CYCLE
- MiRNA-mediated regulation of cell signaling and homeostasis in the early mouse embryo
- (2011) Barbara Pernaute et al. CELL CYCLE
- MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines
- (2011) Giuditta Viticchiè et al. CELL CYCLE
- A non-coding transcript of nephronectin promotes osteoblast differentiation by modulating microRNA functions
- (2011) Shao-Chen Lee et al. FEBS LETTERS
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- Homo sapiensSystemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance
- (2011) Mohamed O. Elhassan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2
- (2011) T. Shatseva et al. JOURNAL OF CELL SCIENCE
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- MicroRNA-125b Induces Cancer Cell Apoptosis Through Suppression of Bcl-2 Expression
- (2011) Aihua Zhao et al. Journal of Genetics and Genomics
- miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
- (2011) Fumihiko Nakatani et al. JOURNAL OF PATHOLOGY
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet-Promoted Murine Colon Cancer: Role of G1 Regulators
- (2011) H. Zhu et al. MOLECULAR CANCER RESEARCH
- Liposomal Delivery of MicroRNA-7-Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
- (2011) K. Rai et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Yingchun Zhao et al. MOLECULAR MEDICINE
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs
- (2011) E L McKinsey et al. ONCOGENE
- Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN
- (2011) Zhongxing Liang et al. PHARMACEUTICAL RESEARCH
- Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy
- (2011) William Weidong Du et al. PLoS One
- MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
- (2011) William CS Cho et al. RNA Biology
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
- (2010) Lei Shi et al. BRAIN RESEARCH
- Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
- (2010) Diana M. Cittelly et al. CARCINOGENESIS
- miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
- (2010) Stephanie Ma et al. Cell Stem Cell
- Gap junctions and connexins as therapeutic targets in cancer
- (2010) Mustapha Kandouz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
- (2010) Xuan Zhou et al. LABORATORY INVESTIGATION
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
- (2010) Laura Poliseno et al. NATURE
- Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis
- (2010) Zina Jeyapalan et al. NUCLEIC ACIDS RESEARCH
- De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures
- (2010) A Ernst et al. ONCOGENE
- MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
- (2010) L Fang et al. ONCOGENE
- Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets
- (2010) Dong Wang et al. PLoS One
- Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions
- (2010) Daniel Y. Lee et al. PLoS One
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
- (2009) A. K. Ghosh et al. BLOOD
- MicroRNA regulates human vitamin D receptor
- (2009) Takuya Mohri et al. INTERNATIONAL JOURNAL OF CANCER
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
- (2009) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-138 might reverse multidrug resistance of leukemia cells
- (2009) Xiaohong Zhao et al. LEUKEMIA RESEARCH
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
- (2009) Y.-Z. Pan et al. MOLECULAR PHARMACOLOGY
- MicroRNA MiR-17 retards tissue growth and represses fibronectin expression
- (2009) Sze Wan Shan et al. NATURE CELL BIOLOGY
- A 3′-Untranslated Region (3′UTR) Induces Organ Adhesion by Regulating miR-199a* Functions
- (2009) Daniel Y. Lee et al. PLoS One
- MicroRNA miR-378 Regulates Nephronectin Expression Modulating Osteoblast Differentiation by Targeting GalNT-7
- (2009) Shireen Kahai et al. PLoS One
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
- (2009) M. Seike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
- (2009) A. Bonauer et al. SCIENCE
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance
- (2008) V G Martinez et al. BRITISH JOURNAL OF CANCER
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- miR2Disease: a manually curated database for microRNA deregulation in human disease
- (2008) Q. Jiang et al. NUCLEIC ACIDS RESEARCH
- MicroRNA miR-328 Regulates Zonation Morphogenesis by Targeting CD44 Expression
- (2008) Chia-Hui Wang et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started